Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00280059Phase 3Completed
A Phase 3 trial of pregabalin in partial epilepsy, sponsored by Viatris. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00280059.